Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wafermine for acute pain after bunionectomy
NCT02541396Phase 2Completed
- Sponsor
- iX Biopharma
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Wafermine in acute pain (7 arms), sponsored by iX Biopharma. Primary endpoint: Total Pain Relief at 24 hours. Started Oct 2015; status: completed.
02
Drugs
Wafermine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02541396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541396.